Differential expression analysis for RNA-Seq data by Gupta, Rashi et al.
International Scholarly Research Network
ISRN Bioinformatics
Volume 2012, Article ID 817508, 8 pages
doi:10.5402/2012/817508
Research Article
Differential Expression Analysis for RNA-Seq Data
Rashi Gupta,1, 2 Isha Dewan,3 Richa Bharti,1 and Alok Bhattacharya4
1 School of Computational and Integrative Sciences, JNU, New Delhi 110067, India
2 CorrZ Technosolutions Pvt. Ltd., Noida 201304, India
3 Indian Statistical Institute, New Delhi 110016, India
4 School of Life Sciences, JNU, New Delhi 110067, India
Correspondence should be addressed to Rashi Gupta, rashi1@live.com
Received 22 June 2012; Accepted 9 August 2012
Academic Editors: D. Piquemal and A. Torkamani
Copyright © 2012 Rashi Gupta et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
RNA-Seq is increasingly being used for gene expression profiling. In this approach, next-generation sequencing (NGS) platforms
are used for sequencing. Due to highly parallel nature, millions of reads are generated in a short time and at low cost. Therefore
analysis of the data is a major challenge and development of statistical and computational methods is essential for drawing
meaningful conclusions from this huge data. In here, we assessed three different types of normalization (transcript parts per
million, trimmed mean of M values, quantile normalization) and evaluated if normalized data reduces technical variability across
replicates. In addition, we also proposed two novel methods for detecting differentially expressed genes between two biological
conditions: (i) likelihood ratio method, and (ii) Bayesian method. Our proposed methods for finding differentially expressed
genes were tested on three real datasets. Our methods performed at least as well as, and often better than, the existing methods for
analysis of differential expression.
1. Introduction
One of the recent methods for gene expression profiling
is RNA-Seq. An advantage of RNA-Seq over other gene
expression profiling technologies is that it allows a compre-
hensive assay that does not require probes for targets to be
specified in advance. It has particularly been used for de
novo detection of splice junctions and allows genome wide
expression profiling of organisms with unknown genome
sequence [1].
By obtaining millions of short reads from the population
of interest and by mapping these reads to the reference
genome, RNA-Seq produces read count data. With enough
reads from a sample, it has the potential to detect and
quantify biologically significant RNAs with low and mod-
erate abundances. Before detecting biologically significant
RNAs, systematic technical variations due to experimental
variability need to be removed retaining effects resulting
from the biological process of interest. This process is also
known as normalization. Various procedures for normaliza-
tion of RNA-Seq have been proposed in literature, such as
transcripts parts per million [2], trimmed mean of M values
[3], and quantile normalization [4]. Though these methods
have been frequently used, no comparative analysis has been
presented so far.
Previous methods for identification of differential
expressed genes include Bloom et al. [5] who identified
differential expression by taking log ratio of the transcript
counts; Hoen et al. [6] used a Student’s t-test and
alternatively also applied a Bayesian model of Veˆncio et al.
[7]. Marioni et al. [8] and Bullard et al. [4] suggested to
use Poisson model (and Fisher’s exact test, or a likelihood
ratio test as an approximation to it) to test for differential
expression. Recently published methods, EdgeR [9] and
DESeq [10] use a Negative Binomial distribution to test for
differential expression as it allows for over dispersion. We
also propose two statistical methods for inferring differential
expression for RNA-Seq data. They are likelihood ratio
method and Bayesian method. The methods are generic and
can be applied to data with or without replication.
Methods for normalization, differential expression, along
with the details of the dataset used to test the performance of
our methods are detailed in the next section. Results along
with a systematic comparison are presented on three real
datasets and we conclude with a brief discussion.
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2. Material and Methods
2.1. Data. Datasets used to test the performance of our
methods.
Dataset 1. Marioni et al. [8] conducted RNA-Seq experiment
with liver and kidney of a single human male using Illumina
Genome Analyzer sequencing platform. Each tissue was
sequenced in seven lanes, split across two runs of themachine
and two different cDNA concentrations (1.5 pM, 3 pM). For
this work, we only use data sequenced at 3 pM concentration
(five lanes for each sample) and 17708 Ensembl transcripts
that mapped with the array probes.
Dataset 2. Vaz et al. [11] profiled miRNA expression from
the normal peripheral blood mononuclear cells from two
different individuals and cancer cells of myeloid lineage,
K562 (chronic myelocytic leukemia) and HL60 (acute
promyelocytic leukemia) using Solexa technology.
Dataset 3. Mastrokolias et al. [12] analyzed 6 globin reduced
with 6 nonreduced human whole blood RNA samples using
a tag sequencing method on the Illumina high-throughput
sequencing platform.
3. Normalization
Normalization is a procedure to remove nonbiological
influence on biological data and to make data comparable
across experiments, runs, and lanes. Various normalization
procedures have been proposed in literature for RNA-Seq
and here we evaluate three different normalization methods:
(1) transcripts parts per million, (2) trimmed mean of M
values, (3) quantile normalization. At present, Transcripts
parts per million (TPM) is a standard procedure to normal-
ize RNA-Seq data. Using this method, number of reads of
a transcript/sequence are divided by the total clone count
of the sample and multiplied by 106. Resulting normalized
data is reported as reads (or transcripts) per million for
each sample. One of the major problems with RNA-Seq
data is that while the total number of reads for a sample is
known, the composition of the RNA population is unknown.
Thus, TPM normalization method has its limitations for
datasets with marked different RNA composition. Trimmed
mean of M values (TMM) normalization has been suggested
to remove RNA compositional bias as TMM equates the
overall expression levels of genes between samples by esti-
mation of relative RNA production levels or scale factors.
Another method in use is quantile normalization which
has previously been applied for microarrays. In quantile
normalization, the distribution of read counts in each lane
is matched to a reference distribution defined in terms of
median counts across sorted lanes.
4. Differential Expression
We propose twomethods for inferring differential expression
across two biological conditions with technical replicates,
each of which yields one test statistics per gene: (i) likelihood
ratio method (LRM) (Casella and Berger [13]), (ii) bayesian
method (BM), an extension of technique due to Audic and
Claverie [14] for more than 2 replicates within a condition.
Let xj denotes the observed number of reads mapped to a
gene in replicate j( j = 1, 2, . . .m) under condition-1 and
let yj denotes the observed number of reads mapped to a
gene in replicate j( j = 1, 2, . . . n) for condition-2. Since the
number of reads mapped to a gene represents a small (less
than 5%) fraction of the total number of reads obtained
after sequencing, we assume xj and yj to follow independent
Poisson distribution with different parameters. Methods are
detailed for a gene and the same need to be applied for all
genes.
4.1. Likelihood Ratio Method. For condition-1, xj follows
Poisson distribution with parameters λj , j = 1, 2, . . . ,m with
probability mass function as
p
(
xj
)
= e
−λj λ
xj
j
x j !
, j = 1, 2, . . . ,m, (1)
where λj denotes the true expression level of gene in replicate
j. As xj ’s occur independently, the likelihood function of
x1, x2, . . . xm is given by
L = L(λ1, λ2, . . . , λm | x1, x2, . . . , xm) =
m∏
j=1
e−λj λ
xj
j
x j !
. (2)
To identify genes with similar read count across replicates, we
test the null hypothesis H0 : λ1 = λ2 = · · · = λm = (say, λ)
against the alternative H1 : λi /= λj for some i /= j. Under H0,
the maximum likelihood estimate (MLE) of λ is given by
λ̂ =
∑m
j=1 xj
m
= x
m
, (3)
where x =∑mj=1 xj and under H1, the MLE of λj is given by
λ̂ j = xj , j = 1, 2, . . . ,m. (4)
The likelihood ratio for testing λ1 = λ2 = · · · = λm = (say,
λ) for condition-1 is given by
Λ1 =
supH0L
supH1L
= (x/m)
x
∏m
j=1
(
xj
)xj
= (x)
x
mx
∏m
j=1
(
xj
)xj .
(5)
Similarly, for condition-2, yj follows Poisson distribution
with parameters μj , j = 1, 2, . . . ,n. As derived above, the
likelihood ratio for testing μ1 = μ2 = · · · , μn = (say, μ)
for condition-2 is given by
Λ2 =
(
y
)y
ny
∏n
j=1
(
yj
)yj , (6)
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where y = ∑nj=1 yj . For identifying differentially expressed
genes across the two conditions, for a gene, define x =∑m
j=1 xj and y =
∑n
j=1 yj to be independent Poisson random
variables with parametersmλ and nμ, respectively, and test if
λ /=μ. The joint likelihood of the two conditions is given as
L = L(λ,μ | x1, x2, . . . , xm; y1, y2, . . . , yn
)
=
m∏
j=1
e−λλxj
x j !
·
n∏
j=1
e−μμyj
y j !
,
(7)
and the unconditional MLE’s of λ and μ are given by x/m
and y/n, respectively, MLE of λ under the hypothesis λ = μ is
(x+ y)/(m+n). The likelihood ratio for testing λ = μ is given
by
Λ3 =
(
m
m + n
)x( n
m + n
)y (x + y)x+y
xx yy
. (8)
We reject the null hypothesis for the small values of the
statistic, Λ3.
4.2. Bayesian Method. Back in 1997, the method of Audic
and Claverie was used to establish the probability distri-
bution governing the occurrence of the same rare event in
repeated experiments and was applied for the analysis of
digital gene expression profiles. It was then described for only
2 replicates which we have attempted to extend to 3 or more
replicates and apply to RNA-Seq data. As defined before, x1
represents the number of reads mapped to a gene in replicate
1 of the condition-1 and follows Poisson distribution
p(x1) = e
−λλx1
x1!
, (9)
where λ denotes the actual number of reads mapped to the
gene. Let x2 represents the number of reads mapped to a gene
in replicate 2 of the condition-1. Then,
p(x2 | x1) =
∫∞
0
p(d = λ | x1)p(x2 | d = λ)dλ, (10)
where p(d = λ | x1) in above equation is the posterior
probability of λ given x1 occurrences of a gene in an
experiment and p(x2 | d = λ) = e−λλx2 /x2! is the probability
of drawing x2 observations from Poisson distribution with
parameter λ. Using Bayes Theorem, Veˆncio et al. [7] showed
that,
p(x2 | x1) = (x1 + x2)!
x1!x2!2(x1+x2+1)
, (11)
where the prior distribution p(d = λ) is taken as uniform
distribution over the interval [0,∞]. We extended the above
results when the condition is replicated thrice and
p(x3 | x1, x2) =
∫∞
0
p(d = λ | x1, x2)p(x3 | d = λ)dλ. (12)
From Bayes Theorem,
p(d = λ | x1, x2) = p(x1, x2 | d = λ)p(d = λ)∫∞
0 p(x1, x2 | d = λ)p(d = λ)dλ
. (13)
Again, using uniform prior for λ, we get
p(d = λ | x1, x2) = 2
x1+x2+1e−2λλx1+x2
(x1 + x2)!
, (14)
which is a gamma random variable with scale parameter 2λ.
This gives
p(x3 | x1, x2) = 2
x1+x2+1(x1 + x2 + x3)!
(x1 + x2)!x3!3x1+x2+x3+1
. (15)
Therefore,
p(x3 | x1, x2)p(x2 | x1) = (x1 + x2 + x3)!
x1!x2!x3!3x1+x2+x3+1
. (16)
Similarly, if the condition is replicated m times, we consider
the following probability.
p˜
(
x1, x2, . . . , xp, . . . , xm
)
= p
(
xm | x1, x2, . . . , xp, . . . , xm−1
)
· · · p(x3 | x1, x2)
× p(x2 | x1)
=
(
x1 + x2 + · · · + xp + · · · + xm
)
!
x1!x2! · · · xm!mx1+x2+···+xm+1 .
(17)
In order to find genes with similar read counts within a
condition, we find two numbers a, b such that
a∑
xp=0
p˜
(
x1, x2, . . . , xp, . . . , xm
)
= α,
∞∑
xp=b
p˜
(
x1, x2, . . . , xp, . . . , xm
)
= α.
(18)
Equation (18) implies that if the observation xm of the
mth replicate lies in the interval [a, b] then we conclude
with probability (1 − 2α) that there are no systematic
differences between the replicates. Similarly, the results can
be derived for n replicates of a gene in condition-2 (i.e.,
yj , j = 1, 2, . . . ,n). For Identifying differential expression
across two conditions, define x1 =
∑m
j=1 xj , y1 =
∑n
j=1 yj to
be independent Poisson random variables with parameters
mλ and nμ, respectively, and use (11). Under the Bayesian
method, we can only identify genes that are different across
two conditions if the number of replicates for the two
conditions are the same (i.e., m = n).
5. Results
5.1. Assessing Technical Variability Using Likelihood Ratio
Method. We assessed the variability within technical repli-
cates using Dataset 1 which comprises of liver and kidney tis-
sue, each with five technical replicates and 17708 ENSEMBL
transcripts. Boxplots of unnormalized data from both liver
and kidney samples are shown in Figure 1(a). Variability
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Figure 1: Boxplots of data from five replicates of liver and five replicates of kidney tissue: (a) Unnormalized, (b) Quantile normalized, (c)
TMM normalized, and (d) TPM normalized.
within replicates and also across the two tissues can be clearly
seen. Kidney being more variable was considered for further
analysis.
We evaluate this variability statistically using a likelihood
ratio method detailed in the previous section. The analysis
was performed at 1%, 2.5%, 5%, and 10% levels while
considering two, three, four, and five replicates on the un-
normalized data from kidney. As shown in Table 1, there is a
decrease in the percentage of genes with similar counts as the
number of replicates increases, which is expected; however,
the decreases is only marginal. The percentage of genes with
similar counts also decrease with the increase in the levels.
Thus, Dataset 1 is highly reproducible with few systematic
differences among the replicates.
5.2. Assessing the Impact of Normalization Using Likelihood
Ratio Method. We assess the impact of all three normal-
ization methods using the likelihood ratio method at 1%,
2.5%, 5%, and 10% levels. We used data from liver tissue
with five replicates without normalization, with TMM,
Quantile, and TPM normalization. It can be seen from
Table 2 that the percentage of genes with similar counts
increased after TMM and Quantile normalization and, thus,
reduction in variability after normalization. A gain of 2%
Table 1: Assessing variability across replicates using the likelihood
ratio test on 17708 genes.
No. of
replicates
Percentage (number) of genes with similar count at
different levels
1% 2.5% 5% 10%
2 98.8 (17506) 97.5 (17282) 94.7 (16782) 89.2 (15809)
3 98.4 (17425) 96.6 (17111) 93.9 (16637) 88.5 (15674)
4 97.1 (17202) 94.8 (16795) 91.5 (16209) 85.8 (15197)
5 96.2 (17037) 93.5 (16563) 90.1 (15970) 84.0 (14876)
is achieved after TMM or Quantile normalization while the
performance of TPM normalization was found to be poor.
Similar results were obtained on other two datasets. Figures
1, 2, and 3 represents boxplots of un-normalized, normalized
after TPM, TMM and Quantile for Datasets 1, 2, and 3,
respectively.
5.3. Comparison of Differential Expression Statistics. We
compared the two proposed methods for inferring differ-
entially expressed (DE) genes: Likelihood ratio method and
Bayesian method on Datasets 2 and 3. We used the quantile
normalized data from these datasets.
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Table 2: Assessing variability across replicates before and after normalization using the likelihood ratio method on 17708 genes.
Type of normalization
Percentage (number) of genes with similar count at different levels
1% 2.5% 5% 10%
No normalization 97.6 (17294) 95.7 (16956) 93.1 (16501) 87.5 (15496)
TMM 99.0 (17540) 97.5 (17272) 95.3 (16887) 90.3 (16007)
Quantile 99.0 (17540) 97.6 (17291) 95.2 (16870) 90.3 (16002)
TPM 86.50 (15318) 86.31 (15284) 85.90 (15212) 84.50 (14964)
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Figure 2: Boxplots of data from two replicates of Normal and two replicates of HL60: (a) Unnormalized, (b) Quantile normalized, (c) TMM
normalized, and (d) TPM normalized.
For comparison between any two biological conditions,
the read count values from the conditions can be categorized
under three categories. (1) When both conditions have zero
count. In this situation, nothing can be said about differential
expression between the two conditions. (2)When one sample
has zero or low counts and a reasonable count in the other.
This is an interesting biological phenomena where a gene
is not expressed in one of the conditions. (3) When both
the conditions have reasonable count. We shall evaluate the
performance of our methods based on second and third
category.
For the quantile normalized Normal versus HL60 data
(Dataset 2), 19 miRNAs are absent in either of the two
samples and present with a reasonable count for the other
and 155 miRNAs were present with read count of at least 5
in both the samples. Using the likelihood ratio method at 1%
level of significance, all 19miRNAs absent in either of the two
conditions were identified as DE and out of the 155 miRNAs,
57 were identified as DE. Using the Bayesian method at 1%
level of significance, miRNAs absent in either of the two
conditions were also identified as DE and out of the 155
miRNAs, 58 were identified as DE. Nearly same miRNAs,
except one, were identified as DE using both themethods.We
also analyzed this dataset using DESeq and EdgeR and they
did not identify miRNAs absent in one of the two conditions.
Of the 155 miRNAs, DESeq identified 3 miRNAs as DE with
P value 0.01 and EdgeR identified 4 miRNAs as DE with P
value 0.01. Similar analysis was performed for Normal versus
K562 and globin reduced versus nonreduced samples. See
Additional file 1, 2, and 3 in supplementarymaterial available
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Figure 3: Boxplots of data from six globin reduced with 6 nonreduced human whole blood RNA samples: (a) Unnormalized, (b) Quantile
normalized, (c) TMM normalized, and (d) TPM normalized.
online at doi:10.5402/2012/817508 for detailed analysis and
Table 3 for a systematic comparison between methods for all
three datasets.
From Additional file 1 in supplementary material, it is
clear that likelihood ratio method and Bayesian method give
very similar results for Normal versus HL60 and Normal
versus K562 datasets (Dataset 2). Both methods identified
all miRNAs previously identified as differentially expressed
in Vaz et al. [11]. However, DESeq and EdgeR could not
identify most of the DE miRNAs reported in Vaz et al. [11].
Few miRNAs experimentally verified using RNase protection
assay (RPA) and real-time RT-PCR in Vaz et al. [11] (i.e.,
miR-16, 22, 27a, 192, and let-7g) were identified with high
fold in our analysis. In addition, we also identified differential
expression of miR-181a family of HL60, previously reported
in [15].
For globin reduced versus non-reduced data (Dataset 3),
likelihood method reports 2513 significant genes at 1% level
of significance, Bayesian method reports 2344 at 1% level
of significance, DESeq reports 1505 with P value 0.01 and
EdgeR reports 2987 genes with P value 0.01. From these
numbers alone, it is difficult to comment on the performance
of any method. Figure 4 demonstrates the distribution of
expression strength of the significant gene list obtained from
likelihood ratio method, DESeq, EdgeR, and all genes. One
Table 3: Comparison of methods on different datasets.
Samples Method
Number of genes
present in only
one samples
Number of
genes present in
both samples
Normal
versus HL60
likelihood ratio 19 57
Bayesian 19 58
DESeq 0 3
EdgeR 0 4
Normal
versus K562
likelihood ratio 2 57
Bayesian 2 53
DESeq 0 3
EdgeR 0 1
Globin
reduced
versus
nonreduced
likelihood ratio 7 2513
Bayesian 7 2344
DESeq 5 1505
EdgeR 7 2987
would expect the distribution of the significant gene lists to
roughly follow the expression strength distribution for all
genes. For likelihood ratio method and DESeq, this is true
but not for EdgeR. EdgeR seems to be identifying genes from
all expression strengths and thus not reflection biolog but the
ISRN Bioinformatics 7
Table 4: Confidence interval estimation using the Bayesian
method.
miRNA Count in
normal
Count in
HL60
Confidence
interval
Differentially
expressed
Hsa-let-7g 15117 6236 [1386, 1644] T
Hsa-miR-192 3711 2044 [3514, 3917] T
Hsa-miR-27a 180 67 [139, 230] T
Hsa-miR-140-5p 7 11 [1, 22] F
Hsa-miR-30b∗ 16 30 [5, 35] F
rigidity of its error models. Few genes experimentally verified
in Mastrokolias et al. [12] using qPCR (i.e., CXorf25, HBA1,
HBA2, HBD, HBB) were obtained with high fold values in
our analysis. See additional file 3 in supplementary material
for analysis.
Table 4 shows how a confidence interval was evaluated
in Bayesian method for quantile normalized Normal-HL60
data. Hsa-let-7g has a read count of 15117 in Normal
(condition-1) and 6236 in HL60 (condition-2). Using (18),
for one replicate, we estimated the lower and upper bound
of the confidence interval around Normal as 1386 and 1644.
Read count of 6236 for hsa-let-7g in HL60 lies well outside
the estimated confidence interval (1386, 1644). Thus, the
read count in Normal and HL60 are significantly different
and reported in Table 3 as T(i.e. true). Similar deductions
can be made for others.
6. Discussions
We assessed three different types of normalizations and
showed that though Illumina data is highly replicable before
normalization, normalization further reduces the technical
variability, likelihood ratio method was used to statistically
evaluate variation across replicates. We also presented two
methods for finding differentially expressed genes for RNA-
Seq data with or without replicates, likelihood ratio method
is a general method that does not impose any restriction
on the equality of the number of replicates across the two
conditions. Bayesian method on the other hand can only
be applied if there is equality on the number of replicates
for the two conditions being compared. The performance
of both the methods was compared to DESeq, EdgeR. For
small RNA dataset, likelihood ratio method and Bayesian
method perform similarly but better than EdgeR and DESeq.
For Dataset 3, the distribution of the significant gene lists
from likelihood ratio method and DESeq roughly follows the
expression strength distribution for all genes. However, this
was not true for EdgeR.
For both likelihood ratio method and Bayesian method,
we assume that the underlying distribution for observed
number of reads to be Poisson. Poisson distribution is
intuitively appealing and mathematically easy to handle but
with a limitation that the mean and variance of Poisson
random variable are the same. To avoid this, authors
generally assume negative binomial distribution instead of
Poisson. However, the efficiency of the proposed methods in
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Figure 4: Distributions of expression strengths of all genes and
significant gene list from likelihood ratio method, EdgeR and
DESeq for Dataset 3.
identifying differentially expressed genes, their mathematical
convenience, and simplicity should make these methods
extremely useful.
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